Physician

Richard M Schuman, MD

According to 2025 Medicare claims, Richard Schuman, MD (NPI: 1952344277) practices hematology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is TITAN HEALTH PARTNERS LLC (NPI: 1790396281; TIN: 852303328) and primary practice location at 08820-1103. Schuman is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Schuman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 502 traditional Medicare patients, billed 66,589 HCPCS/CPT codes, and received $1,184,944 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 783 prescription claims across 145 beneficiaries totaling $2,091,331 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 22 claims. Open Payments data shows 30 records totaling $634. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,001,299 to $2,091,331. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,456 to $1,355.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	848	108,321	$1,708,991
2016	855	111,991	$1,639,750
2017	779	97,980	$1,689,790
2018	786	101,845	$1,760,465
2019	712	118,987	$1,702,310
2020	655	97,435	$1,384,441
2021	544	71,093	$1,281,552
2022	629	84,430	$1,372,977
2023	514	68,222	$1,276,624
2024	502	66,589	$1,184,944

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	157	800	$1,001,299
2016	162	800	$953,252
2017	164	750	$1,191,944
2018	168	943	$2,012,436
2019	165	815	$1,732,182
2020	161	924	$2,580,271
2021	148	938	$2,341,993
2022	163	975	$2,996,778
2023	139	900	$2,548,752
2024	145	783	$2,091,331

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	44	$22,088
2016	N/R	123	$26,618
2017	N/R	80	$3,620
2018	N/R	210	$13,139
2019	N/R	248	$18,571
2020	N/R	79	$5,775
2021	N/R	13	$955
2022	N/R	69	$2,074
2023	N/R	22	$1,068
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	264	616	$111
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	103	316	$71
36415	Insertion of needle into vein for collection of blood sample	225	521	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	244	660	$8
85027	Complete blood cell count (red cells, white blood cell, platelets), automated test	80	179	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	20	562	$322,715
Tasigna	Nilotinib Hcl	13	364	$258,187
Somatuline Depot	Lanreotide Acetate	26	744	$244,627
Venclexta	Venetoclax	12	360	$142,311
Brukinsa	Zanubrutinib	21	630	$123,270

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$634	Aveo Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$5,000	Cornerstone Specialty Network LLC

Explore More Providers

FAQ

What Medicare data is available for Richard M. Schuman, MD?

Tedicare shows public-source Medicare data for Richard M. Schuman, MD (NPI 1952344277), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard M. Schuman, MD have ACO affiliation data?

Richard M. Schuman, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Richard M. Schuman, MD?

Richard M. Schuman, MD is linked to TITAN HEALTH PARTNERS LLC (billing NPI 1790396281) in the available physician profile data.

Does Richard M. Schuman, MD have Open Payments data?

Richard M. Schuman, MD has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.